
    
      All patients will receive IL-2 at 600,000 international units per kilogram (kg) by
      intraveneous bolus (IVB) every 8 hours for 14 planned doses with an additional cycle 14 days
      after the first. Ipilimumab 3mg/kg IV infusion Q3 weeks.
    
  